Boardroom Alpha
Boardroom Alpha
IBOC · Current Report (Form 8-K) · Filed May 12, 2026

International Bancshares Corp — Current Report (Form 8-K)

Form
8-K
Filed
May 12, 2026
Period
May 12, 2026
Ticker
IBOC
Accession
0001104659-26-059135
Boardroom Alpha · Filing insights

IBC amends By-Laws to remove 3% derivative-suit threshold and exclusive forum; ends jury-trial waiver; effective May 12, 2026.

About International Bancshares Corp
Market cap
$4.5B
1Y TSR
+14.8%
3Y TSR
+19.2%
Board grade
B-
Sector
Financial Services
CEO
Dennis E Nixon
Last annual meeting: May 18, 2026 · View full International Bancshares Corp profile →

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 12, 2026

 

INTERNATIONAL BANCSHARES CORPORATION

(Exact name of registrant as specified in its charter)

 

Texas   000-9439   74-2157138
(State or other jurisdiction
of incorporation)
 

(Commission
File Number)

  (IRS Employer
Identification No.)

 

1200 San Bernardo, Laredo, Texas   78040-1359
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code:   (956) 722-7611

 

None

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 250.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading Symbol(s)   Name of each exchange on which registered:
Common Stock, $1.00 par value   IBOC   The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

  

 

 

 

 

Item 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On May 12, 2026, the Board of Directors of International Bancshares Corporation (“IBC”) approved and adopted the Third Amended and Restated By-Laws of IBC (the “By-Laws”) to remove the requirement that a shareholder or group of shareholders may not institute or maintain a derivative proceeding unless that shareholder or group of shareholders beneficially own three percent of IBC’s issued and outstanding common stock, par value $1.00 per share, at the time such derivative proceeding is instituted.

 

In addition, the By-Laws were amended to eliminate the exclusive forum clause which previously designated the Texas Business Court located in the Fourth Business Court Division or, if such court lacked jurisdiction the United States District Court for the Southern District of Texas, or if such court lacked jurisdiction the state district court of Webb County as the sole and exclusive forum for any filing or claim unless agreed to otherwise. The amendments to the By-Laws no longer require that each shareholder, director, and officer irrevocably and unconditionally waive any right they may have to a trial by jury in any legal action, proceeding, cause of action, or counterclaim concerning any internal entity claim and in any other claim, action, or proceeding against IBC, to the fullest extent permitted by applicable law.

 

The By-Laws became effective on May 12, 2026.

 

A copy of the By-Laws is attached as Exhibit 3.1, to this Current Report on Form 8-K, and is incorporated herein by reference in its entirety.

 

Item 9.01Financial Statements and Exhibits.

 

3.1Third Amended and Restated By-Laws
104Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  INTERNATIONAL BANCSHARES CORPORATION
   
   
  By: /s/ Dennis E. Nixon
    Dennis E. Nixon,
President and
Chairman of the Board
     
   
May 12, 2026  

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from International Bancshares Corp (IBOC)

Reference

Frequently asked questions

When did International Bancshares Corp file this 8-K?
International Bancshares Corp (IBOC) filed this Current Report (Form 8-K) with the SEC on May 12, 2026. The accession number assigned by EDGAR is 0001104659-26-059135.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
IBC amends By-Laws to remove 3% derivative-suit threshold and exclusive forum; ends jury-trial waiver; effective May 12, 2026. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find International Bancshares Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K International Bancshares Corp has filed under CIK 315709, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer